Perspective Therapeutics (NYSE:CATX) Receives Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Perspective Therapeutics (NYSE:CATX – Free Report) in a report published on Wednesday morning,Benzinga reports. The brokerage currently has a $10.00 target price on the stock. Several other equities research analysts have also weighed in on CATX. Wedbush reiterated an “outperform” rating and issued a $11.00 price […]
HC Wainwright reissued their buy rating on shares of Perspective Therapeutics (NYSE:CATX – Free Report) in a report published on Wednesday morning,Benzinga reports. The brokerage currently has a $10.00 target price on the stock. Several other equities research analysts have also weighed in on CATX. Wedbush reiterated an “outperform” rating and issued a $11.00 price […]
